Our top pick for
Medley Management Inc is an asset management business based in the US. Medley Management shares (MDLY) are listed on the NYSE and all prices are listed in US Dollars. Medley Management employs 40 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.42|
|52-week range||$0.42 - $14.75|
|50-day moving average||$4.85|
|200-day moving average||$7.07|
|Wall St. target price||$3.00|
|Dividend yield||$0.03 (0.52%)|
|Earnings per share (TTM)||$-4.26|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||N/A|
|1 month (2021-09-22)||N/A|
|3 months (2021-07-26)||-77.89%|
|6 months (2021-04-26)||-92.39%|
|1 year (2020-10-26)||-28.81%|
|2 years (2019-10-25)||-87.16%|
|3 years (2018-10-26)||5.275|
|5 years (2016-10-26)||9.25|
Valuing Medley Management stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medley Management's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medley Management's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medley Management's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medley Management's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 million.
The EBITDA is a measure of a Medley Management's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$33.3 million|
|Operating margin TTM||6.31%|
|Gross profit TTM||$13.8 million|
|Return on assets TTM||3.11%|
|Return on equity TTM||0%|
|Market capitalisation||$18.3 million|
TTM: trailing 12 months
There are currently 180,174 Medley Management shares held short by investors – that's known as Medley Management's "short interest". This figure is 21.9% up from 147,865 last month.
There are a few different ways that this level of interest in shorting Medley Management shares can be evaluated.
Medley Management's "short interest ratio" (SIR) is the quantity of Medley Management shares currently shorted divided by the average quantity of Medley Management shares traded daily (recently around 2.0 million). Medley Management's SIR currently stands at 0.09. In other words for every 100,000 Medley Management shares traded daily on the market, roughly 90 shares are currently held short.
However Medley Management's short interest can also be evaluated against the total number of Medley Management shares, or, against the total number of tradable Medley Management shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medley Management's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Medley Management shares in existence, roughly 60 shares are currently held short) or 0.1667% of the tradable shares (for every 100,000 tradable Medley Management shares, roughly 167 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medley Management.
Find out more about how you can short Medley Management stock.
We're not expecting Medley Management to pay a dividend over the next 12 months.
Medley Management's shares were split on a 1:10 basis on 1 November 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Medley Management shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Medley Management shares which in turn could have impacted Medley Management's share price.
Over the last 12 months, Medley Management's shares have ranged in value from as little as $0.42 up to $14.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medley Management's is 1.8033. This would suggest that Medley Management's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medley Management Inc. is an investment holding company and operate and control all of the business and affairs of Medley LLC and its subsidiaries. Medley Management Inc. was incorporated on June 13, 2014 and is based in New York, New York. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.